ESSENTAVAX
Live / Applied — Response to non-final action entered (as of 03 Feb 2026)
What this means for you
Not registered yet, but its 22 May 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99198002
- Mark type
- Stylized text
- Filed
- 22 May 2025
- Attorney of record
- Alicia M. Passerin
Goods and services
- Class 005 — Pharmaceuticals: Medicinal preparations for the treatment and prevention of cancer and infectious diseases; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the prevention of infectious diseases; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for the prevention of cancer; Biological preparations for the prevention and treatment of cancer and infectious diseases; Vaccines; all of the foregoing comprising human adenovirus or interleukin-15
Owner
- ImmunityBio, Inc., San Diego, CA, US
Prosecution history
- 03 Feb 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 03 Feb 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 03 Feb 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 03 Nov 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 03 Nov 2025 — NON-FINAL ACTION E-MAILED
- 03 Nov 2025 — NON-FINAL ACTION WRITTEN
- 24 Oct 2025 — ASSIGNED TO EXAMINER
- 23 Oct 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 22 May 2025 — APPLICATION FILING RECEIPT MAILED
- 22 May 2025 — NEW APPLICATION ENTERED